Back to 
BlackRock Advisors LLC
BlackRock Advisors LLC
LGND
Showing 0 of 10 quarters
Position history for BlackRock Advisors LLC's holdings in Ligand Pharmaceuticals Incorporated
As of its last 13F, for Q4 2016, BlackRock Advisors held 21,653 shares of LGND (Ligand Pharmaceuticals), worth $2.2M. It reduced the position by 997 shares (-4.4%) from Q3 2016. BlackRock Advisors held LGND from Q3 2014 to Q4 2016, across 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.